Members: Login
Programme

Programme: Thursday

Day One




0845‑0900
LT1 / G.29
Opening Ceremony

0900‑0945
LT1 / G.29

ACB-AACC Transatlantic Lecture
Drug Screening with Immunoassays: Breaking Up Is Hard To Do
Dr Dennis Dietzen - President, AACC

0945‑1030

Break & Industry
Sponsored
Workshops

Industry Sponsored Workshops
0950‑1030
LT3 / G.86              






0950‑1030
LT4 / G.78              
Alpha Laboratories Ltd
FIT to practice?
Prof Callum Fraser
University of Dundee
Sally Benton

Royal Surrey County Hospital
Nigel D'Souza
Croydon University Hospital 
Immundiagnostik AG
Faecal Bile Acids: a new way to diagnose Bile Acid Diarrhoea
Lauren Hughes
Royal Wolverhampton NHS Trust 

Parallel Sessions


Paediatrics for the Non-specialist/ DGH Clinical & Laboratory Teams
(Chair: Lesley Tetlow)

New Approaches to Clinical Problems & Drug Assays
(Chair: Tony Tetlow)

Point of Care Testing (POCT)
(Chairs: Danielle Freedman & Rebecca Powney)

1030‑1100
LT1 / G.29

Time to be on alert for paediatric AKI
Prof Rachel Lennon
Royal Manchester Children's Hospital

1030‑1100
LT2 / G.44

Influence of pre-analytics with particular reference to drug assays
Dr Mike Cornes
Worcester Royal Hospital
1030‑1115
LT3 / G.86
Does POCT add value?
Prof Sverre Sandberg, University of Bergen
Dr Danielle Freedman, Luton and Dunstable Hospital

1100‑1130
LT1 / G.29

Investigating hypoglycaemia: when laboratory medicine is the icing on the cake!
Dr Mars Skae
Royal Manchester Children's Hospital
1100‑1130
LT2 / G.44
Changing trends in street drugs: the greatest challenge facing clinical toxicology screening services
Dr Loretta Ford
City Hospital, Birmingham
1115‑1145
LT3 / G.86
The value of POCT in Acute care
Dr Dominic Giles
Norfolk and Norwich University Hospital

1130‑1200
LT1 / G.29

Disorders of sexual development: what support can a DGH lab provide?
Dr Leslie Perry
Croydon University Hospital
1130‑1200
LT2 / G.44
Immunobiologics and antibodies to them
Dr Mandy Perry
Royal Devon and Exeter Hospital
1145‑1215
LT3 / G.86
The Clinical Scientists Board The value of POCT in Primary care
Dr Prash Patel
Berkshire Primary Care
1200‑1230
LT1 / G.29

Old and new approaches to paediatric reference ranges in 2018
Dr Tim Lang
University Hospital of North Durham
1200‑1230
LT2 / G.44
PCSK9 Mabs: new lipid-modifying therapy
Dr Handrean Soran
Manchester Royal Infirmary
1215‑1230
LT3 / G.86
Re-vote and summary
Prof Sverre Sandberg
Dr Danielle Freedman

1230‑1430

Exhibition, Posters & Lunch

Industry Sponsored Workshops
1300‑1340
LT4 / G.78              








1300‑1340
LT3 / G.86
Thermo Fisher Scientific OY
Fully automated LC-MS: Fantasy or Reality? 
Anna Milan
Royal Liverpool and Broadgreen University Hospital NHS Trust
Sally Benton
Berkshire and Surrey Pathology Services
John Shepherd
Hull & East Yorkshire NHS Trust

Weqas 
EQA & ISO15189
Gareth Davies, Weqas

Parallel Sessions

Access and Equity in Laboratory Medicine
(Chair: Lance Sandle)

ACB Medal Award
(Chair: Ian Young - ACB President)

1430‑1500
LT1 / G.29
Parity for mental and physical illness: everybody's business?
Professor Dame Sue Bailey
Children and Young People's Mental Health Coalition
1430‑1450
LT2 / G.44




1450‑1510
LT2 / G.44





1510‑1530
LT2 / G.44





1530‑1550
LT2 / G.44




1550‑1610
LT2 / G.44



1610‑1630
LT2 / G.44
Assessing the vitamin B12 status of adults with type 2 diabetes mellitus on metformin 
Dr Giles Aldworth
Royal Victoria Hospital, Belfast 

Evaluation of fibroblast growth factor-21 enzyme immunosorbent assay method and its performance for the investigation of mitochondrial disease 
Dr Gayani Weerasinghe
Oxford University Hospitals 

Implications for the monitoring of patients with multiple myeloma during treatment with the immunotherapy daratumumab 
Dr Sally Thirkettle
Christie NHS Foundation Trust 

Tacrolimus and creatinine analysis by LC-MS/MS using Mitra® microsampling devices 
David Marshall
Wythenshawe Hospital 

Biological variability of cardiac troponins in chronic kidney disease
Rebecca Jones
William Harvey Hospital 

Fatal opioid poisoning: an emerging role for fentanyl and fentanyl analogues in the United Kingdom 
Dr Edmund Rab
Northern General Hospital, Sheffield
1500‑1530
LT1 / G.29
POCT in the community
Dr Amir Hannan
Haughton Thornley Medical Centre, Hyde
1530‑1600
LT1 / G.29
Equity of access: using a system approach to improve shared use and understanding of laboratory test results 
Dr
Paul Rowlands
Derbyshire Healthcare Foundation Trust
1600‑1630
LT1 / G.29
Improving access to health for hard to reach communities: the Health Mela model
Prof Romesh Gupta
National Forum for Health and Wellbeing
1630‑1700
LT1 / G.29
ACB Foundation Lecture
Increasing access and equity in laboratory diagnostics
Dr Martin Myers - Royal Preston Hospital

Updated 4 June 2018

© Copyright The Association for Clinical Biochemistry and Laboratory Medicine
The Association for Clinical Biochemistry and Laboratory Medicine, 130-132 Tooley Street LONDON SE1 2TU
Tel: 020 7403 8001 Fax: 020 7403 8006